The Treatment of Severe Staphylococcal Infections with Vancomycin

Article1 August 1961The Treatment of Severe Staphylococcal Infections with VancomycinDONALD W. WOODLEY, M.D., WENDELL H. HALL, M.D., PH.D., F.A.C.P.DONALD W. WOODLEY, M.D., WENDELL H. HALL, M.D., PH.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-55-2-235 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe efficacy of vancomycin (Vancocin®—Lilly) in the treatment of severe staphylococcal infections is becoming well established. According to several authors it is now the agent of choice if the organism is penicillin-resistant (1-3). Vancomycin has a bactericidal action for staphylococci, and as yet no resistant strains have been reported in clinical practice. Toxicity is often bothersome, but it is rarely serious or a cause for discontinuing therapy. A summary of our experience with this drug in 25 cases of serious staphylococcal infections will be presented, along with a review of the literature on vancomycin. The following cases are reported in...References1. GERACIHEILMAN JEFR: Vancomycin in the treatment of staphylococcal endocarditis. Proc. Mayo Clin. 35: 316, 1960. MedlineGoogle Scholar2. KIRBYPERRYBAUER WMDMAW: Treatment of staphylococcal septicemia with vancomycin: report of thirty-three cases. New Engl. J. Med. 262: 49, 1960. CrossrefMedlineGoogle Scholar3. PETERSDORFROSEMINCHEWKEENEBENNETT RGMCHBWRIL: The sensitivity of hemolytic staphylococci to a series of antibiotics. Arch. Intern. Med. 105: 398, 1960. CrossrefMedlineGoogle Scholar4. ELLIOTTHALL HJWH: Studies on synergism with twelve antibiotics against thirty hospital strains of Staphylococcus aureus. J. Lab. Clin. Med. 50: 242, 1957. MedlineGoogle Scholar5. HALL WH: Rate of development of resistance in Staphylococcus aureus to erythromycin in combination with oleandomycin, vancomycin, or dihydrostreptomycin. J. Lab. Clin. Med. 56: 83, 1960. MedlineGoogle Scholar6. GERONIMUS LH: Inoculum size and the apparent sensitivity of staphylococci to penicillins. New Engl. J. Med. 263: 349, 1960. CrossrefMedlineGoogle Scholar7. WAISBRENKLEINERMANSKEMPBRATCHER BALJG: Comparative clinical effectiveness and toxicity of vancomycin, ristocetin, and kanamycin. Arch. Intern. Med. 106: 179, 1960. CrossrefGoogle Scholar8. GERACIHEILMANNICHOLSWELLMANROSS JEFRDRWEGT: Some laboratory and clinical experiences with a new antibiotic, vancomycin. Proc. Mayo Clin. 31: 564, 1956. MedlineGoogle Scholar9. QUIECOLLINCARDLE PGMJB: Neomycin-resistant staphylococci. Lancet 2: 124, 1960. CrossrefMedlineGoogle Scholar10. FINEGOLD S: Personal communication. Google Scholar11. WOODLEY DW: Staphylococcal pseudomembranous enterocolitis. J. Lancet 80: 111, 1960. MedlineGoogle Scholar12. MCCORMICKSTARKPITTENGERPITTENGERMCGUIRE MHWMGERCJM: Vancomycin, a new antibiotic. I. Chemical and biologic properties, in Antibiotics Annual, 1955-1956, Medical Encyclopedia, Inc., New York, p. 606. Google Scholar13. ZIEGLERWOLFEMCGUIRE DWRNJM: Vancomycin, a new antibiotic. II. In vitro antibacterial studies, in Antibiotics Annual, 1955-1956, Medical Encyclopedia, Inc., New York, p. 612. Google Scholar14. GRIFFITHPECK RSFB: Vancomycin, a new antibiotic. III. Preliminary clinical and laboratory studies, in Antibiotics Annual, 1955-1956, Medical Encyclopedia, Inc., New York, p. 619. Google Scholar15. ANDERSONWORTHHARRISCHEN RCHMPNKK: Vancomycin, a new antibiotic. IV. Pharmacologic and toxicologic studies, in Antibiotics Annual, 1956-1957, Medical Encyclopedia, Inc., New York, p. 75. Google Scholar16. LEEANDERSONCHEN CCRCKK: Vancomycin, a new antibiotic. V. Distribution, excretion, and renal clearance, in Antibiotics Annual, 1956-1957, Medical Encyclopedia, Inc., New York, p. 82. Google Scholar17. KIRBYPERRYLANE WMDMJL: Present status of vancomycin therapy of staphylococcal and streptococcal infections, in Antibiotics Annual, 1958-1959, Medical Encyclopedia, Inc., New York, p. 580. Google Scholar18. KIRBYDIVELBISS WMCL: Vancomycin: clinical and laboratory studies, in Antibiotics Annual, 1956-1957, Medical Encyclopedia, Inc., New York, p. 107. Google Scholar19. GRIFFITH RS: Vancomycin: continued clinical studies, in Antibiotics Annual, 1956-1957, Medical Encyclopedia, Inc., New York, p. 118. Google Scholar20. EHRENKRANZ NJ: The clinical evaluation of vancomycin in treatment of multi-antibiotic refractory staphylococcal infections, in Antibiotics Annual, 1958-1959, Medical Encyclopedia, Inc., New York, p. 587. Google Scholar21. ROTHENBERG HJ: Anaphylactoid reaction to vancomycin. J. A. M. A. 171: 1101, 1959. CrossrefMedlineGoogle Scholar22. WALLACECARSON IRNA: Staphylococcal septicemia treated with vancomycin in the presence of chronic renal failure. Lancet 1: 519, 1960. CrossrefMedlineGoogle Scholar23. GERACIHEILMANNICHOLSWELLMAN JEFRDRWE: Antibiotic therapy of bacterial endocarditis: VII. Vancomycin for acute micrococcal endocarditis: preliminary report. Proc. Mayo Clin. 33: 172, 1958. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: DONALD W. WOODLEY, M.D.; WENDELL H. HALL, M.D., PH.D., F.A.C.P.Affiliations: Minneapolis, MinnesotaReceived for publication February 20, 1961.From the Veterans Administration Hospital, Minneapolis, Minnesota, and the Department of Medicine, University of Minnesota Medical School.Supported by a grant from Eli Lilly and Co., Indianapolis, lnd.Requests for reprints should be addressed to Wendell H. Hall, M.D., Chief, Medical Service, Veterans Administration Hospital, 54th St. and 48th Ave. South, Minneapolis 17, Minn. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAntibiotic-Associated Diarrhea Beyond C. Difficile : A Scoping ReviewRetrospective review of vancomycin-induced nephrotoxicity in patients with leukemiaBiopsy-Proven Acute Tubular Necrosis due to Vancomycin ToxicityBridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clonesVancomycin-Induced Acute Interstitial NephritisAdverse effects of vancomycin in children: a review of 22 casesPrevention of gram-positive sepsis in neonates weighing less than 1500 gramsOtotoxicity of Vancomycin and AnaloguesVancomycin Therapeutic Drug Monitoring: Is it Necessary?In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873Comparison of the Effectiveness of Various Antibiotics in the Treatment of Methicillin-Susceptible Staphylococcus aureus Experimental Infective EndocarditisRevised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureusVancomycin- and erythromycin-induced hearing loss in humansVancomycin Ototoxicity and NephrotoxicityHome Intravenous Antibiotic TherapyVancomycin: A ReviewComparative antibacterial activity of Vancocin and generic vancomycinVancomycin-Induced NeutropeniaVancomycin and the KidneyVancomycin: An UpdateVancomycin enhancement of experimental tobramycin nephrotoxicityDrug Information Analysis ServiceRe-emergence of methicillin-resistant staphylococcus aureus causing severe infectionVancomycinRetrospective study of the toxicity of preparations of vancomycin from 1974 to 1981Vancomycin Ototoxicity in a Patient with Normal Renal FunctionPETER G. TRABER, M.D., DONALD P. LEVINE, M.D.Vancomycin-induced hypotensionHazards of Rapid Administration of VancomycinPHILIPPA NEWFIELD, M.D., MICHAEL F. ROIZEN, M.D.Vancomycin RevisitedFRANCIS V. COOK, M.D., W. EDMUND FARRAR Jr., M.D., F.A.C.P.Inhibition of dental caries in school children by topically applied vancomycinA Review of Vancomycin: After 15 Years of UseEffect of a Topically Applied 3 % Vancomycin Gel on Streptococcus mutans on Different Tooth SurfacesTopical vancomycin as a deterrent to bacteremias following dental proceduresAntimicrobial Control of Bacterial Plaque and Calculus and the Effects of these Agents on Oral FloraAspectos gerais das septicemias e bacteriemias estafilocócicas no adultoTreatment of oral lesions with topically applied vancomycin hydrochlorideStaphylococcal Enterocolitis—Treatment with Oral VancomycinMOHAMMED Y. KHAN, M.B., WENDELL H. HALL, M.D., F.A.C.P.Cephalothin in Serious Bacterial InfectionSTEVEN L. MERRILL, M.D., ALVIN DAVIS, M.D., BERNARD SMOLENS, M.D., SYDNEY M. FINEGOLD, M.D., F.A.C.P.The Treatment of Staphylococcal Infection with Nafcillin with a Discussion of Staphylococcal NephritisBRUCE C. NYDAHL, M.D., WENDELL H. HALL, M.D., F.A.C.P.The Treatment of Staphylococcal InfectionsThe Newer Penicillins II. Clinical Experiences with Methicillin and OxacillinHAROLD J. SIMON, M.D., PH.D., LOWELL A. RANTZ, M.D., F.A.C.P.Studies on the Antibiotic Therapy of Serious Staphylococcal Infections I. Comparison of the In Vitro Activity of Methicillin, Phenethicillin, and Other AntibioticsF. ROBERT FEKETY JR., M.D., LEIGHTON E. CLUFF, M.D.The Diagnostic Dilemma of Severe Staphylococcal InfectionsROBERT I. WISE, M.D., PH.D. 1 August 1961Volume 55, Issue 2 Page: 235-249 Keywords Drugs Endocarditis Enterocolitis Hospital medicine Osteomyelitis Sepsis Staphylococcal infection Toxicity Urea Vancomycin ePublished: 1 December 2008 Issue Published: 1 August 1961 PDF downloadLoading ...